GUANABENZ ACETATE

GUANABENZ ACETATE 구조식 이미지
카스 번호:
23256-50-0
상품명:
GUANABENZ ACETATE
동의어(영문):
br750;Wytens;WY-8678;FLA-137;Tenelid;Wytensin;Wy 8678 acetate;GUANABENZ ACETATE;GuanabenzAcetate>GUANABENZACETATE,USP
CBNumber:
CB9491023
분자식:
C10H12Cl2N4O2
포뮬러 무게:
291.13
MOL 파일:
23256-50-0.mol
MSDS 파일:
SDS

GUANABENZ ACETATE 속성

녹는점
227-229℃ (decomposition)
저장 조건
Keep in dark place,Inert atmosphere,Room temperature
용해도
H2O: 11 mg/mL
물리적 상태
고체
물리적 상태
단단한 모양
색상
하얀색
Merck
14,4558
안정성
흡습성
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xn
위험 카페고리 넘버 22
안전지침서 22-36/37/39-45
유엔번호(UN No.) UN 2811 6.1/PG 3
WGK 독일 3
RTECS 번호 MF0382000
위험 등급 6.1(b)
포장분류 III
HS 번호 2928002500
유해 물질 데이터 23256-50-0(Hazardous Substances Data)
그림문자(GHS): GHS hazard pictograms
신호 어: Danger
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H301 삼키면 유독함 급성 독성 물질 - 경구 구분 3 위험 GHS hazard pictograms P264, P270, P301+P310, P321, P330,P405, P501
예방조치문구:
P264 취급 후에는 손을 철저히 씻으시오.
P264 취급 후에는 손을 철저히 씻으시오.
P270 이 제품을 사용할 때에는 먹거나, 마시거나 흡연하지 마시오.
P301+P310 삼켰다면 즉시 의료기관(의사)의 진찰을 받으시오.
P405 밀봉하여 저장하시오.
P501 ...에 내용물 / 용기를 폐기 하시오.

GUANABENZ ACETATE C화학적 특성, 용도, 생산

용도

antihypertensive

일반 설명

Guanabenz acetate, [(2,6-dichlorobenzylidene)amino]guanidine monoacetate (Wytensin), is acentral 2-adrenergic agonist that reduces the release of norepinephrinefrom the neuron when stimulated. The effect ofthe drug results in decreased sympathetic tone in the heart,kidneys, and peripheral blood vessels. The drug does not produceorthostatic hypotension.

생물학적 활성

α 2 -adrenergic agonist and IGRS (imidazoline I 2 binding site) selective ligand.

Pharmacokinetics

The oral bioavailability of guanabenz is 70 to 80%. Following an oral dose, the hypotensive effect of guanabenz begins within 1 hour, peaks within 2 to 7 hours, and is diminished within 6 to 8 hours. It has an elimination half-life averaging 4 to 14 hours. The blood pressure response can persist for at least 12 hours. Following IV dosing, guanabenz is distributed into the CNS, with brain concentrations 3 to 70 times higher than concurrent plasma concentrations. Guanabenz is approximately 90% bound to plasma proteins. In patients with hepatic or renal impairment, its elimination half-life may be prolonged.
Guanabenz is metabolized principally by hydroxylation to its inactive metabolite, 4-hydroxyguanabenz, which is eliminated in the urine as its glucuronide (major) and sulfate conjugates. Guanabenz and its inactive metabolites are excreted principally in urine, with approximately 70 to 80% of its oral dose excreted in urine within 24 hours and approximately 10–30% in feces via enterohepatic cycling. Approximately 40% of an oral dose of guanabenz is excreted in urine as 4-hydroxyguanabenz and its glucuronide, and less than 5% is excreted unchanged. The remainder is excreted as unidentified metabolites and their conjugates.

Clinical Use

Overall, the therapeutic applications for guanabenz are similar to those of clonidine and other α2-adrenergic agonists. One advantage for guanabenz is its once-a-day dosing schedule. Guanabenz has been used in diabetic patients with hypertension without adverse effect on the control of or therapy for diabetes, and it has been effective in hypertensive patients with chronic obstructive pulmonary disease, including asthma, chronic bronchitis, or emphysema. Guanabenz has been used alone or in combination with naltrexone in the management of opiate withdrawal in patients physically dependent on opiates and undergoing detoxification. Guanabenz also has been used as an analgesic in a limited number of patients with chronic pain

부작용

Overall, the frequency of adverse effects produced by guanabenz is similar to that produced by clonidine and the other α2-adrenergic agonists, but the incidence is lower. As with the other centrally active sympatholytics (e.g., clonidine), abrupt withdrawal of guanabenz may result in rebound hypertension, but the withdrawal syndrome symptoms appear to be less severe.

GUANABENZ ACETATE 준비 용품 및 원자재

원자재

준비 용품


GUANABENZ ACETATE 공급 업체

글로벌( 149)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Shanghai Daken Advanced Materials Co.,Ltd
+86-371-66670886
info@dakenam.com China 15928 58
Nanjing ChemLin Chemical Industry Co., Ltd.
025-83697070
product@chemlin.com.cn CHINA 3012 60
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22968 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
Unipharm pharmaceutical industry Co., Ltd
536-8266195 +8613953676784
lee@unipharm-sd.com China 1206 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167
1026@dideu.com China 9358 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 29271 58
AFINE CHEMICALS LIMITED
0571-85134551
info@afinechem.com CHINA 15377 58
Baoji Guokang Bio-Technology Co., Ltd.
0917-3909592 13892490616
gksales1@gk-bio.com China 9339 58
Dayang Chem (Hangzhou) Co.,Ltd.
571-88938639 +8617705817739
info@dycnchem.com CHINA 52867 58

GUANABENZ ACETATE 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved